Skip to main content
. 2020 Jul 24;36(6):366–375. doi: 10.1089/jop.2020.0022

FIG. 7.

FIG. 7.

Schematic depiction of a drug-core MPP. The inset is showing 15-s trajectories of drug-core MPPs (particle size of ∼270 nm in this example) and a negative control (200 nm polystyrene nanoparticles) in human cervicovaginal mucus as observed by fluorescence microscopy. The inset is adapted from Cu et al.61